Healthcare provider profile · identity verified

Bela Glantsman, M.D.

Family Practice · MUNDELEIN, IL · NPI 1750347803

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	341	49
Alprazolam	Alprazolam	210	37
Atorvastatin Calcium	Atorvastatin Calcium	209	55
Amlodipine Besylate	Amlodipine Besylate	192	58
Lisinopril	Lisinopril	190	51
Zolpidem Tartrate	Zolpidem Tartrate	173	31
Losartan Potassium	Losartan Potassium	172	45
Gabapentin	Gabapentin	161	31
Omeprazole	Omeprazole	144	37
Metoprolol Succinate	Metoprolol Succinate	137	33
Metformin Hcl	Metformin Hcl	129	33
Clonazepam	Clonazepam	122	22
Metoprolol Tartrate	Metoprolol Tartrate	122	38
Oxycodone Hcl	Oxycodone Hcl	109	16
Levothyroxine Sodium	Levothyroxine Sodium	98	25
Lidocaine	Lidocaine	97	17
Furosemide	Furosemide	90	24
Albuterol Sulfate Hfa	Albuterol Sulfate	76	18
Eliquis	Apixaban	73	suppressed
Diclofenac Sodium	Diclofenac Sodium	71	17
Diazepam	Diazepam	70	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	69	21
Pantoprazole Sodium	Pantoprazole Sodium	66	17
Rosuvastatin Calcium	Rosuvastatin Calcium	65	17
Clopidogrel	Clopidogrel Bisulfate	61	16
Famotidine	Famotidine	61	14
Isosorbide Mononitrate Er	Isosorbide Mononitrate	61	21
Tramadol Hcl	Tramadol Hcl	57	15
Trulicity	Dulaglutide	57	11
Liothyronine Sodium	Liothyronine Sodium	54	12
Fluticasone Propionate	Fluticasone Propionate	53	20
Potassium Chloride	Potassium Chloride	53	12
Atenolol	Atenolol	50	suppressed
Carvedilol	Carvedilol	48	12
Duloxetine Hcl	Duloxetine Hcl	46	suppressed
Lorazepam	Lorazepam	45	suppressed
Ibuprofen	Ibuprofen	39	suppressed
Januvia	Sitagliptin Phosphate	39	suppressed
Linzess	Linaclotide	39	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	39	suppressed
Xarelto	Rivaroxaban	39	suppressed
Hydralazine Hcl	Hydralazine Hcl	38	17
Creon	Lipase/Protease/Amylase	37	suppressed
Ozempic	Semaglutide	37	suppressed
Temazepam	Temazepam	37	suppressed
Allopurinol	Allopurinol	34	suppressed
Carisoprodol	Carisoprodol	34	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	34	suppressed
Hydrocortisone	Hydrocortisone	34	suppressed
Glipizide	Glipizide	33	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	33	suppressed
Meclizine Hcl	Meclizine Hcl	32	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	30	suppressed
Citalopram Hbr	Citalopram Hydrobromide	29	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	29	suppressed
Azithromycin	Azithromycin	28	23
Morphine Sulfate Er	Morphine Sulfate	28	suppressed
Clonidine Hcl	Clonidine Hcl	27	suppressed
Trazodone Hcl	Trazodone Hcl	27	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	26	suppressed
Fluconazole	Fluconazole	26	12
Np Thyroid	Thyroid,pork	26	suppressed
Azelastine Hcl	Azelastine Hcl	25	suppressed
Celecoxib	Celecoxib	25	suppressed
Montelukast Sodium	Montelukast Sodium	25	suppressed
Prednisone	Prednisone	25	suppressed
Synthroid	Levothyroxine Sodium	25	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	24	suppressed
Meloxicam	Meloxicam	24	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	24	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	22	suppressed
Sertraline Hcl	Sertraline Hcl	21	suppressed
Sucralfate	Sucralfate	21	suppressed
Ventolin Hfa	Albuterol Sulfate	21	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	20	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	20	suppressed
Propranolol Hcl	Propranolol Hcl	20	suppressed
Simvastatin	Simvastatin	20	suppressed
Pregabalin	Pregabalin	19	suppressed
Spiriva Respimat	Tiotropium Bromide	19	suppressed
Memantine Hcl	Memantine Hcl	18	suppressed
Nystatin	Nystatin	18	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	18	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	17	suppressed
Epinephrine	Epinephrine	17	suppressed
Fentanyl	Fentanyl	17	suppressed
Glimepiride	Glimepiride	17	suppressed
Jardiance	Empagliflozin	17	suppressed
Ondansetron Odt	Ondansetron	17	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	17	suppressed
Tizanidine Hcl	Tizanidine Hcl	17	suppressed
Ubrelvy	Ubrogepant	17	suppressed
Ezetimibe	Ezetimibe	16	suppressed
Amoxicillin	Amoxicillin	15	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	14	12
Donepezil Hcl	Donepezil Hcl	14	suppressed
Lidocaine Hcl Viscous	Lidocaine Hcl	14	suppressed
Naproxen	Naproxen	14	suppressed
Valacyclovir	Valacyclovir Hcl	14	suppressed
Bupropion Xl	Bupropion Hcl	13	suppressed
Cephalexin	Cephalexin	13	suppressed
Doxepin Hcl	Doxepin Hcl	13	suppressed
Ondansetron Hcl	Ondansetron Hcl	13	suppressed
Sotalol	Sotalol Hcl	13	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	13	suppressed
Alendronate Sodium	Alendronate Sodium	12	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	12	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	12	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	12	suppressed
Glipizide Er	Glipizide	12	suppressed
Gvoke Hypopen 2-Pack	Glucagon	12	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	12	suppressed
Metformin Hcl Er	Metformin Hcl	12	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	11	suppressed
Cyanocobalamin Injection	Cyanocobalamin (Vitamin B-12)	11	suppressed
Premarin	Estrogens, Conjugated	11	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error